Northwire Canada EditionThursday, October 15, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4% GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4%
Financings Neutral

Cheelcare Announces a Non-Brokered Private Placement to Raise up to $1.5 Million

Small-cap mobility device maker scales commercialization but relies on recurring capital raises to fund cash burn.

By The Northwire Desk — AI Analysis Jun 11, 2026 · 16:31 CHER · 1.55 Cheelcare Inc.
Executive Summary
  • Cheelcare Inc. announced a non-brokered private placement to raise up to $1.5 million CAD by issuing up to 1,000,000 units at $1.50 per unit.
  • Each unit consists of one common share and one-half of a common share purchase warrant.
  • Warrants carry a $2.25 exercise price, a two-year term, and an acceleration clause if the TSXV share price reaches $3.00 for 10 consecutive trading days.
  • Proceeds are earmarked for general working capital, product development, and commercialization activities.
  • The offering is subject to TSX Venture Exchange approval and customary closing conditions, with a statutory hold period of four months and one day.
Material Impact
  • The private placement is a standard small-cap capital raise designed to extend operating runway amid active commercialization and manufacturing scale-up.
  • The $1.50 unit price aligns with the stock's recent trading low ($1.51 on June 10), indicating a modest discount typical of non-brokered placements.
  • Direct dilution from the equity component is approximately 5% of outstanding shares, with additional potential dilution from warrant exercises.
  • The financing does not alter the company's business model, product roadmap, or reimbursement status. It simply provides liquidity to fund the cash burn observed in recent quarters.
  • Given the company's prior $1.0 million unsecured note closing in February 2026 and the tight cash position reported in March, this raise is operationally necessary but not transformative.
CHER · Price
Company Overview
  • Cheelcare Inc. designs and manufactures mobility solutions, primarily the Companion power-assist device for manual wheelchairs and the Curio robotic complex-rehab power wheelchair.
  • The company operates a B2B and B2C distribution model through a network of over 500 dealers globally, including major North American networks and over 20 U.S. Veterans Affairs medical centers.
  • Recent operational milestones include the completion of a 16,000 sq ft manufacturing facility, pilot production of the Curio platform, and the achievement of 2,000 cumulative Companion unit sales.
  • The business model relies on insurance reimbursement pathways (U.S. Medicare/Medicaid, Ontario ADP) to reduce private-pay barriers and drive predictable revenue growth.
Read the original news release →

More from Cheelcare Inc.

Jun 18, 2026 · 07:31

Cheelcare Announces Upsizing of Non-Brokered Private Placement to $3.0 Million

Financings May 28, 2026 · 07:31

Cheelcare Secures Canadian IP Moat as Sales Momentum Builds Amidst Dilution Risks

M&A / Property May 11, 2026 · 07:31

Cheelcare extends its booking streak as Companion reimbursement catalyst takes hold, but the Curio regulatory journey and thin balance sheet keep risk elevated.

Production / Operations Apr 09, 2026 · 07:31

Cheelcare launches first Curio robotic wheelchair, turning R&D into revenue

Production / Operations Mar 25, 2026 · 07:31

Cheelcare Scales Revenue but Cash Burn Threatens Runway as Stock Fades from Peak

Earnings Feb 18, 2026 · 07:31

Cheelcare Closes $1.0 Million Unsecured Note Financing

Financings